- |||||||||| NB002 / Neologics Biosci
NB002, a novel therapeutic antibody targeting unique epitope on TIM-3 presenting potent antitumor activity (Section 23; Poster Board #10) - Mar 14, 2023 - Abstract #AACR2023AACR_8470;
These data could potentially explain novel features of NB002, restoring both acquired and innate immunity which could lead cold tumor to hot tumor.In summary, these data showed that NB002 is a potent anti-TIM-3 antibody with pre-clinical properties. A phase 1 study is planned and patients with advanced metastatic solid tumors will be recruited.
|
